secwatch.observer — SEC 8-K summary
======================================

Issuer:     INTEGRA LIFESCIENCES HOLDINGS CORP (IART)
CIK:        0000917520
Form:       8-K
Filed at:   2023-10-25T23:59:59+00:00
Accession:  0000917520-23-000069
Event type: earnings
Sentiment:  negative
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Integra Q3 revenues down 0.7%, GAAP EPS $0.24; adjusts FY23 guidance lower
--------------------------------------------------------------------------

- Q3 revenue $382.4M, reported -0.7% YoY; organic ex-Boston +7.1%.
- GAAP EPS $0.24 vs $0.60; adjusted EPS $0.76 vs $0.86.
- Codman Specialty Surgical +7.4% organic; Tissue Technologies -15.1% organic due to Boston recall returns.
- FY23 revenue guidance cut to $1.541-1.547B; adjusted EPS $3.10-3.14.
- Boston facility restart on track for Q4'23; commercial distribution expected mid-to-late Q2'24.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/917520/000091752023000069/0000917520-23-000069-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/917520/000091752023000069/iart-20231025.htm
  HTML page:      https://secwatch.observer/filing/0000917520-23-000069

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer